2026年2月2日，康哲药业控股有限公司（下称“康哲药业”，股票代码：00867）披露2026年1月股份变动月报。报告期为2026年1月1日至2026年1月31日。
本月公司注册股本维持在20,000,000,000股普通股，每股面值为0.005美元，注册股本总额为1亿美元。截至1月底，已发行股份总数为2,439,528,512股，且无库藏股；与上月底相比，本期并无新增发行或购回注销活动。
康哲药业确认，截至2026年1月31日，公司已符合香港联交所有关上市规则规定的最低公众持股量，并遵守了所有适用监管要求。本次月报由公司秘书吴三燕签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.